Skip to main content

Table 2 Lipid plasma concentrations of HDL subclasses

From: Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses

  Group Subclasses
HDL 2b HDL 2a HDL 3a HDL 3b HDL 3c
TC (mg/dL) Control 11.74 ± 1.11 5.71 ± 0.44 11.19 ± 0.80 6.16 ± 0.47 6.16 ± 0.42
CAD 9.27 ± 1.12 4.26 ± 0.25* 7.92 ± 0.64* 4.59 ± 0.35* 3.43 ± 0.24†
FC (mg/dL) Control 3.53 ± 0.55 1.34 ± 0.19 2.64 ± 0.45 1.08 ± 0.18 1.13 ± 0.16
CAD 4.00 ± 0.34 1.60 ± 0.13 3.06 ± 0.27 1.46 ± 0.12 1.14 ± 0.11
EC (mg/dL) Control 14.62 ± 1.84 7.33 ± 0.72 13.73 ± 1.53 8.66 ± 0.73 8.02 ± 0.57
CAD 8.26 ± 1.85 4.47 ± 0.43* 9.55 ± 1.01* 5.29 ± 0.59* 3.84 ± 0.33†
TG (mg/dL) Control 8.56 ± 1.10 4.63 ± 0.56 8.40 ± 0.79 4.13 ± 0.46 4.37 ± 0.45
CAD 10.14 ± 0.97 4.20 ± 0.43 6.56 ± 0.43 2.97 ± 0.21* 1.66 ± 0.23†
PH (mg/dL) Control 21.08 ± 1.07 9.52 ± 0.54 18.20 ± 1.12 10.11 ± 0.90 10.65 ± 1.52
CAD 25.55 ± 2.00 10.42 ± 0.76 16.58 ± 1.23 8.86 ± 0.66 7.18 ± 0.63
  1. TC total cholesterol; FC free cholesterol; EC esterified cholesterol; TG triglycerides; PH phospholipids
  2. Data are shown as mean ± SE. n = 15 by group. Student’s t test †p < 0.01, and *p < 0.05 vs. control group